These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20094816)

  • 1. The molecular basis of carcinogenesis in Barrett's esophagus.
    Souza RF
    J Gastrointest Surg; 2010 Jun; 14(6):937-40. PubMed ID: 20094816
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma.
    Fitzgerald RC
    Gut; 2006 Dec; 55(12):1810-20. PubMed ID: 17124160
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
    Fang Y; Chen X; Bajpai M; Verma A; Das KM; Souza RF; Garman KS; Donohoe CL; O'Farrell NJ; Reynolds JV; Dvorak K
    Ann N Y Acad Sci; 2013 Oct; 1300():187-199. PubMed ID: 24117642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barrett's esophagus: evolutionary insights from genomics.
    Jankowski JA; Satsangi J
    Gastroenterology; 2013 Apr; 144(4):667-9. PubMed ID: 23439235
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
    Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
    Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression.
    Maslyonkina KS; Konyukova AK; Alexeeva DY; Sinelnikov MY; Mikhaleva LM
    Cancer Med; 2022 Jan; 11(2):447-478. PubMed ID: 34870375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of and genetic susceptibility to esophageal cancer.
    Bajpai M; Das KM; Lefferts J; Lisovsky M; Mashimo H; Phillips WA; Srivastava A; To H
    Ann N Y Acad Sci; 2014 Sep; 1325():40-8. PubMed ID: 25266013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27 and Barrett's esophagus: a review*.
    Ellis FH; Loda M
    Dis Esophagus; 2004; 17(2):113-7. PubMed ID: 15230722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma.
    Fein M
    Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carcinogenesis of Barrett's esophagus].
    Endo T; Sugawara N; Shinomura Y
    Nihon Rinsho; 2005 Aug; 63(8):1357-61. PubMed ID: 16101221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
    Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
    Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's esophagus: cancer and molecular biology.
    Gibson MK; Dhaliwal AS; Clemons NJ; Phillips WA; Dvorak K; Tong D; Law S; Pirchi ED; Räsänen J; Krasna MJ; Parikh K; Krishnadath KK; Chen Y; Griffiths L; Colleypriest BJ; Farrant JM; Tosh D; Das KM; Bajpai M
    Ann N Y Acad Sci; 2013 Oct; 1300():296-314. PubMed ID: 24117650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
    Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular markers and genetics in cancer development.
    Hormi-Carver K; Souza RF
    Surg Oncol Clin N Am; 2009 Jul; 18(3):453-67. PubMed ID: 19500736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural selection in neoplastic progression of Barrett's esophagus.
    Maley CC; Reid BJ
    Semin Cancer Biol; 2005 Dec; 15(6):474-83. PubMed ID: 16043360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of Barrett's esophagus and adenocarcinoma.
    Dvorak K; Goldman A; Kong J; Lynch JP; Hutchinson L; Houghton JM; Chen H; Chen X; Krishnadath KK; Westra WM
    Ann N Y Acad Sci; 2011 Sep; 1232():381-91. PubMed ID: 21950830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barrett's esophagus: ordering the events that lead to cancer.
    Reid BJ; Barrett MT; Galipeau PC; Sanchez CA; Neshat K; Cowan DS; Levine DS
    Eur J Cancer Prev; 1996 Dec; 5 Suppl 2():57-65. PubMed ID: 9061296
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
    Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.